The present study investigates whether Shenfu injection ameliorates myocardial injury in rats with yang-deficient CHF by mediating ferroptosis through the Akt/GSK-3β/Nrf2 pathway, thereby providing a theoretical basis for its clinical optimization and application. The gene discussed is AKT1; the disease is congestive heart failure.